| Structure | Chemical Name | CAS | MF |
|
Imidazo[1,2-a]pyrimidine-6,7-diamine, 2,3-dihydro-5-methyl- (9CI)
|
693208-62-7
|
C7H11N5
|
|
Carbamodithioic acid, (2-cyanoethyl)methyl- (9CI)
|
693208-91-2
|
C5H8N2S2
|
|
1,3,5-Triazin-2-amine,6-ethoxy-4-(2-furanyl)-1,4-dihydro-(9CI)
|
693209-45-9
|
C9H12N4O2
|
|
Imidazo[1,2-c]pyrimidin-7(1H)-one, 5,8-diamino-2,3-dihydro- (9CI)
|
693210-80-9
|
C6H9N5O
|
|
Piperazinimine, 1-phenyl- (9CI)
|
693210-97-8
|
C10H13N3
|
|
Bicyclo[3.1.1]heptan-2-ol, 2-(aminomethyl)-1-methyl- (9CI)
|
693211-25-5
|
C9H17NO
|
|
Furo[3,4-c]pyridin-7-amine, 1,3-dihydro-6-methyl- (9CI)
|
693211-39-1
|
C8H10N2O
|
|
693213-58-0
|
693213-58-0
|
C6H11NO2
|
|
3-Azetidinecarbonitrile,1-(aminoacetyl)-(9CI)
|
693216-36-3
|
C6H9N3O
|
|
Cyclopentanecarboxamide, 2-amino-N-methyl-4-methylene-, (1R,2S)-rel- (9CI)
|
693217-14-0
|
C8H14N2O
|
|
Benzeneacetamide, 4-amino-N-[6-amino-1-butyl-3-[(2-fluorophenyl)methyl]-1,2,3,4-tetrahydro-2,4-dioxo-5-pyrimidinyl]-
|
693217-34-4
|
C23H26FN5O3
|
|
2-Propenoic acid, 3-(4-hydroxyphenyl)-, MonosodiuM salt, (2E)-
|
693218-34-7
|
C9H9NaO3
|
|
Benzamide, N-(4-ethyl-2-pyridinyl)- (9CI)
|
693219-69-1
|
C14H14N2O
|
|
1,2,3-Thiadiazole-5-carboxamide,N-(4-ethyl-2-pyridinyl)-4-methyl-(9CI)
|
693219-71-5
|
C11H12N4OS
|
|
2-(2,3-Dihydro-1,4-benzodioxin-6-yl)imidazo[1,2-a]pyrimidine
|
693219-80-6
|
C14H11N3O2
|
|
R,R-3-fluorophenylglycidol
|
693220-50-7
|
C9H9FO2
|
|
HYMENIALDISINE ANALOGUE #1
|
693222-51-4
|
C15H13N5O2
|
|
Phosphonic acid, methyl-, mono(4-ethylphenyl) ester (9CI)
|
693223-28-8
|
C9H13O3P
|
|
Cyclobutanone, 3,3-diethyl-2,2-dimethyl-, semicarbazone (4CI)
|
693225-07-9
|
C11H21N3O
|
|
Cyclobutanone, 3,3-diethyl-2,2,4-trimethyl-, semicarbazone (4CI)
|
693226-60-7
|
C12H23N3O
|
|
1H-Imidazolium, 1,2-dimethyl-3-(2-propenyl)-, bromide
|
693226-62-9
|
C8H13BrN2
|
|
1-n-Butyl-2,3-dimethylimidazolium hydrogen sulfate
|
693226-64-1
|
C9H17N2.HSO4
|
|
Cyclobutanone, 2,3,3-triethyl-, semicarbazone (4CI)
|
693226-81-2
|
C11H21N3O
|
|
Cyclobutanone, 2,3,3-triethyl-4-methyl-, semicarbazone (4CI)
|
693226-85-6
|
C12H23N3O
|
|
S5011
|
693227-30-4
|
|
|
CYC-116
|
693228-63-6
|
C18H20N6OS
|
|
N-[4-(4-acetylpiperazin-1-yl)phenyl]guanidine
|
693230-06-7
|
C13H19N5O
|
|
2-Furancarboxamide, 5-[[4-(1-methylethyl)phenoxy]methyl]-N-3-pyridinyl-
|
693231-81-1
|
C20H20N2O3
|
|
2-Benzyloxy-4-bromobenzonitrile
|
693232-03-0
|
C14H10BrNO
|
|
3-(Benzyloxy)-4-bromobenzonitrile
|
693232-05-2
|
C14H10BrNO
|
|
2-BroMo-3-hydroxybenzonitrile
|
693232-06-3
|
C7H4BrNO
|
|
5-(benzyloxy)-2-bromobenzonitrile
|
693232-07-4
|
C14H10BrNO
|
|
3-Fluoro-2-(4-morpholino)pyridine
|
693235-16-4
|
C9H11FN2O
|
|
5-(2-Fluorophenyl)-3-(3-nitrophenyl)-1,2,4-oxadiazole
|
693236-20-3
|
C14H8FN3O3
|
|
1H-Indene-1,2-diol, octahydro- (9CI)
|
693236-88-3
|
C9H16O2
|
|
4-Piperidinecarboxylic acid, 1-(4-bromobenzoyl)-
|
693237-87-5
|
C13H14BrNO3
|
|
Prop-2-enyl((2,4,6-trimethylphenyl)sulfonyl)amine
|
693238-00-5
|
C12H17NO2S
|
|
4-Amino-2-benzylamino-6-phenyl-1,3,5-triazine
|
693241-47-3
|
C16H15N5
|
|
EG1
(Pax2 inhibitor EG1)
|
693241-54-2
|
C22H18N2O5
|
|
3-Pyridinecarboxamide,N-[2-hydroxy-5-(1-methylethyl)phenyl]-(9CI)
|
693242-18-1
|
C15H16N2O2
|
|
Cyclohexanecarboxanilide, 2,2,6-trimethyl- (4CI)
|
693243-53-7
|
C16H23NO
|
|
1,2-Cyclohexanediol, 4-propyl- (4CI)
|
693244-64-3
|
C9H18O2
|
|
1H-Azirino[2,3,1-ij]quinoline(9CI)
|
693245-24-8
|
C9H7N
|
|
1-Oxaspiro[2.5]octane-4,5,6,7-tetrol,(3S,4S,5R,6S,7R)-(9CI)
|
693245-36-2
|
C7H12O5
|
|
5-Chloro-3-cyanobenzotrifluoride
|
693245-52-2
|
C8H3ClF3N
|
|
cis-3-Methyl-4-aMinotetrahydropyran
|
693245-60-2
|
C6H13NO
|
|
(3S,4S)-3-Methyltetrahydro-2H-pyran-4-aMine
|
693245-62-4
|
C6H13NO
|
|
4-methyloxan-4-amine
|
693245-65-7
|
C6H13NO
|
|
2H-Pyran-3(4H)-one,dihydro-4,4-dimethoxy-(9CI)
|
693245-80-6
|
C7H12O4
|
|
2H-Pyran-2-carboxylicacid,tetrahydro-4-oxo-,methylester(9CI)
|
693245-83-9
|
C7H10O4
|
|
Pentitol, 1,5-anhydro-2,4-dideoxy-2-(2-hydroxyethyl)- (9CI)
|
693245-86-2
|
C7H14O3
|
|
3-Oxabicyclo[3.1.0]hexane-6-carboxylic acid
|
693248-53-2
|
C6H8O3
|
|
Carbamic acid, 3-oxabicyclo[3.1.0]hex-6-yl-, 1,1-dimethylethyl ester (9CI)
|
693248-54-3
|
C10H17NO3
|
|
3-Oxabicyclo[3.1.0]hexan-6-aMine hydrochloride
|
693248-55-4
|
C5H10ClNO
|
|
Cyclopentanecarboxylic acid, 1-[(1R,2R)-2-cyanocyclopropyl]-3-oxo-, rel- (9CI)
|
693249-54-6
|
C10H11NO3
|
|
8-Oxabicyclo[3.2.1]octan-3-amine,(3-endo)-(9CI)
|
693249-62-6
|
C7H13NO
|
|
3-benzyl-tetrahydropyran-4-one
|
693249-64-8
|
C12H14O2
|
|
Benzonitrile, 3-(aminomethyl)-5-(trifluoromethyl)- (9CI)
|
693250-09-8
|
C9H7F3N2
|
|
2H-1-Benzopyran-2-one, 3,4-dihydro-3,4,7,8-tetrahydroxy- (9CI)
|
693250-21-4
|
C9H8O6
|
|
Pyrrolidine, 1-(2-ethyl-2H-1-benzopyran-2-yl)- (9CI)
|
693251-76-2
|
C15H19NO
|
|
3-Furancarboxamide,tetrahydro-2,2-dimethyl-N-(2-methylphenyl)-5-oxo-(9CI)
|
693253-83-7
|
C14H17NO3
|
|
4,6-Dimethyl-2-(pyrrolidin-1-yl)nicotinonitrile
|
693254-24-9
|
C12H15N3
|
|
Benzenecarbothioamide, 4-ethoxy-N,N-dimethyl- (9CI)
|
693255-37-7
|
C11H15NOS
|
|
3-Cyclohexene-1-carboxylicacid,4-methyl-6-[(3-pyridinylamino)carbonyl]-
|
693255-84-4
|
C14H16N2O3
|
|
2-(Benzyloxy)-4-bromobenzoic acid
|
693257-19-1
|
C14H11BrO3
|
|
4-Methyl-α-[2-(methylamino)ethyl]benzenemethanol
|
693261-93-7
|
C11H17NO
|
|
N-(2-methyl-5-nitro-phenyl)-2-(4-methylphenyl)sulfanyl-ethanamide
|
693264-45-8
|
C16H16N2O3S
|
|
1H-Pyrrole-3-methanol, 2,5-dimethyl-1-[4-(phenylmethoxy)phenyl]-
|
693265-13-3
|
C20H21NO2
|
|
1-Pyrrolidinecarboxamide,N-(1,2-dimethyl-1H-benzimidazol-5-yl)-(9CI)
|
693265-76-8
|
C14H18N4O
|
|
2-[2-chloro-4-(hydroxymethyl)phenoxy]-N-(4-methylphenyl)acetamide
|
693267-97-9
|
C16H16ClNO3
|
|
3,5-Dichloro-4-[(3-nitrophenyl)methoxy]-benzenemethanol
|
693269-84-0
|
C14H11Cl2NO4
|
|
2-[4-(hydroxymethyl)phenoxy]-N-phenylacetamide
|
693270-23-4
|
C15H15NO3
|
|
3-[[2-Chloro-4-(hydroxymethyl)-6-methoxyphenoxy]methyl]-benzoic acid
|
693270-48-3
|
C16H15ClO5
|
|
3-bromo-2,4-dimethylbenzaldehyde
|
693285-59-5
|
C9H9BrO
|
|
Boronic acid, (3-methoxy-2,6-dimethylphenyl)- (9CI)
|
693285-60-8
|
C9H13BO3
|
|
4-Piperidinecarboxamide,4-hydroxy-(9CI)
|
693285-66-4
|
C6H12N2O2
|
|
[5-(1-Methylethyl)-1H-indazol-4-yl] boronic acid
|
693285-67-5
|
C10H13BN2O2
|
|
[3-(1-Methylethyl)-1H-indazol-4-yl] boronic acid
|
693285-69-7
|
|
|
4-Bromo-3-isopropyl-1H-indazole
|
693285-71-1
|
|
|
AURORA KA-6269
|
693286-31-6
|
C7H5Cl2NO2
|
|
6-Isopropyl-2-methylbenzeneboronic acid
|
693286-55-4
|
C10H15BO2
|
|
Boronic acid, B-(5-Methyl-1H-indol-4-yl)-
|
693286-67-8
|
C9H10BNO2
|
|
Oxiranecarboxylic acid, 2-(trifluoromethyl)-, (2S)- (9CI)
|
693287-30-8
|
C4H3F3O3
|
|
Oxiranecarboxylic acid, 2-(trifluoromethyl)-, (2R)- (9CI)
|
693287-31-9
|
C4H3F3O3
|
|
Hydrazinecarboxylic acid, (tetrahydro-4H-pyran-4-ylidene)-, 1,1-dimethylethyl
|
693287-78-4
|
C10H18N2O3
|
|
Hydrazinecarboxylic acid, 2-(tetrahydro-2H-pyran-4-yl)-, 1,1-dimethylethyl ester
|
693287-79-5
|
C10H20N2O3
|
|
1-Piperidinecarboxylicacid,4-hydrazino-,ethylester(9CI)
|
693287-94-4
|
C8H17N3O2
|
|
Hydrazine, [3-methyl-1-(2-methylpropyl)butyl]-
|
693288-02-7
|
C9H22N2
|
|
Ethanone, 1-(4-amino-3-ethyl-5-methylphenyl)-2-chloro- (9CI)
|
693288-44-7
|
C11H14ClNO
|
|
1-Pentanol,2-(diethylamino)-(9CI)
|
693288-49-2
|
C9H21NO
|
|
N-{4-chloro-2-[(1,3-dioxo-1,3-dihydro-2H-isoindol-2-yl)methyl]phenyl}-2-hydroxybenzamide
|
693288-97-0
|
C22H15ClN2O4
|
|
2H-1-Benzopyran-2-one, 6-ethyl-7,8-dihydroxy-4-methyl- (9CI)
|
693289-02-0
|
C12H12O4
|
|
Formamide, N-bicyclo[4.2.0]octa-1,3,5-trien-7-yl-N-methyl- (9CI)
|
693289-54-2
|
C10H11NO
|
|
Formamide, N-methyl-N-[(E)-(6-methylene-2,4-cyclohexadien-1-
|
693289-62-2
|
C10H11NO
|
|
Formamide, N-methyl-N-[(Z)-(6-methylene-2,4-cyclohexadien-1-
|
693289-63-3
|
C10H11NO
|
|
4-Thiazolidinone,3,5-diethyl-2-(ethylimino)-(9CI)
|
693763-44-9
|
C9H16N2OS
|
|
3-[(3-Methylphenoxy)methyl]piperidine
|
693764-34-0
|
C13H19NO
|
|
Proline, 1-(2-aminoethyl)- (9CI)
|
693764-52-2
|
C7H14N2O2
|
|
Flunarizine EP Impurity D
|
693765-11-6
|
C26H26F2N2
|
|
2(1H)-Pyrimidinethione,1,4,5,6-tetramethyl-(9CI)
|
693765-82-1
|
C8H12N2S
|